Akorn appoints 2 executivesBeth Zelnick Kaufman is joining Akorn as executive vice president, chief legal officer and corporate secretary while Sandhya Goyal is assuming the role of senior vice president and chief scientific officer. Xiromed intros generic EnablexEnablex and its generics had a market value of $11.2 million for the 12-month period ended February 2021, according to IQVIA. Hikma debuts docetaxel injection Docetaxel injection had a market value of roughly $10 million in the 12 months ended March 2021, according to IQVIA. Alembic intros nystatin and triamcinolone acetonide cream Alembic's generic nystatin and triamcinolone acetonide cream provides a treatment for cutaneous candidiasis. Teva intros erythromycin tablets Erythromycin oral tablets had a market value of more than $49 million, according to January 2021 IQVIA data. Amphastar obtains FDA OK for morphine sulfate injection Amphastar has sold and marketed under the "grandfather" exemption to the FDA's "Prescription Drug Wrap-Up" program. Sun Pharma launches authorized generic of Absorica Sun’s isotretinoin capsules are available in dosage strengths of 10 mg, 20 mg, 25 mg, 30 mg 35 mg and 40 mg. Elite, Prasco launch loxapine capsules Elite's loxapine succinate capsules provide treatment for schizophrenia. Teva launches 1st generic of Absorica Isotretinoin capsules had annual U.S. sales of more than $158 million for the year ended February 2021, according to IQVIA data. AAM supports introduction of Protecting Access to Affordable Medicines Act The Protecting Access to Affordable Medicines Act helps ensure patients maintain uninterrupted access to low-cost medicines. First Previous 127 128 129 130 131 Next Last
